TALPHERA, INC. Deferred Revenue, Revenue Recognized (Deprecated 2016-01-31)
TALPHERA, INC. (TLPH) reported Deferred Revenue, Revenue Recognized (Deprecated 2016-01-31) of $4.80 million for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-11-10.
Discontinued › Income Statement › Other Income
us-gaap:DeferredRevenueRevenueRecognized · last filed 2014-11-10
- TALPHERA, INC. deferred revenue, revenue recognized (deprecated 2016-01-31) for the quarter ending 2014-09-30 was $4.80M.
- TALPHERA, INC. deferred revenue, revenue recognized (deprecated 2016-01-31) for the quarter ending 2014-06-30 was $71.00K.
- TALPHERA, INC. deferred revenue, revenue recognized (deprecated 2016-01-31) for the quarter ending 2014-03-31 was $95.00K.
| Period end | Deferred Revenue, Revenue Recognized (Deprecated 2016-01-31) 3 month | Deferred Revenue, Revenue Recognized (Deprecated 2016-01-31) 6 month | Deferred Revenue, Revenue Recognized (Deprecated 2016-01-31) 9 month |
|---|---|---|---|
| 2014-09-30 | $4.80M 10-Q · filed 2014-11-10 | $5.00M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $71.00K 10-Q · filed 2014-08-11 | $166.00K 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $95.00K 10-Q · filed 2014-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |